Spike Protein-Mediated Compound Immunodeficiency Cascade in COVID-19 and Long-COVID
International Journal of Sciences: Basic and Applied Research · 01.01.2026
DOI: 10.13140/rg.2.2.28202.48325 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Sciences: Basic and Applied Research, erschienen am 01.01.2026. Verfasst von Joachim Gerlach und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Five years after the emergence of SARS-CoV-2, converging clinical evidence reveals a progressive compound immunodeficiency affecting a substantial and growing proportion of the global population. This manuscript presents a systematic, source-agnostic framework identifying ten interconnected layers of immune degradation driven by persistent spike protein exposure from both viral infection and vaccination [1,2]. We delineate eight primary mechanisms of immunodeficiency: (I) bone marrow HSPC invasion and hematopoietic disruption, (II) decimation of secondary lymphoid organs, (III) persistent spike protein in PBMCs with Th1/Th2 dysregulation, (IV) multi-level Type I interferon suppression, (V) microbiome destruction affecting the gut–immune axis, (VI) T cell exhaustion with syncytial formation and NK cell impairment, (VII) variant-driven expansion of immune evasion, and (VIII) autoimmune paradox through anti-idiotype antibodies and molecular mimicry [1,2,4,5,6,7,8]. Beyond receptor-mediated entry, we describe a multi-layered intracellular damage cascade: mitochondrial hijacking with viral dsRNA enrichment in mitochondria, OXPHOS suppression, and inhibited mitophagy [24,25,27,28,36].; viroporin-mediated calcium dysregulation activating the NLRP3 inflammasome [31,32,39,40].; direct and paracrine cellular senescence propagating through SASP-mediated bystander effects [16,19,20,21,22].; and heritable epigenetic reprogramming of HSPCs that persists for up to one year and is conveyed through differentiation to progeny immune cells [3,43,44,45]. We further present a systematic receptor mapping analysis of fifteen SARS-CoV-2 entry receptors across twenty-seven immune cell types, revealing that long-term hematopoietic stem cells (LT-HSCs) express the highest ACE2 levels of any hematopoietic cell (10–65% of purified HSCs), placing the source of all immune cells at the apex of the vulnerability hierarchy [61,62,63]. Spike protein triggers NLRP3 inflammasome-mediated pyroptosis and suppresses colony-forming capacity in HSPCs [61,63]. The unified escape mutation theory demonstrates that antibody-driven selection has simultaneously expanded receptor tropism beyond ACE2, enabling variants to target immune cells from stem cell to mature effector through redundant alternative pathways [1,2]. ACE2-enhanced late Omicron variants (LP.8.1, NB.1.8.1) disproportionately target the highest-ACE2 population—HSCs—cutting off immune cell supply at the source across all lineages. The analysis reveals an ‘activation trap’ whereby immune response upregulates receptors (CD147, DPP4, TfR1, GRP78) that render responding T cells vulnerable [12,14]. Eight empirically testable predictions are derived from the integrated model.
Schlagwörter
Zitieren
APA
Gerlach, J., Baig, A. M., Jaeger, B. R., Brogna, C., König, B., McCairn, K., Rixey, C., Mavberg, P., Triantos, P., +, U. E., & Seneff, S. (2026). Spike Protein-Mediated Compound Immunodeficiency Cascade in COVID-19 and Long-COVID. International Journal of Sciences: Basic and Applied Research. https://doi.org/10.13140/rg.2.2.28202.48325
Vancouver
Gerlach J, Baig AM, Jaeger BR, Brogna C, König B, McCairn K, et al. Spike Protein-Mediated Compound Immunodeficiency Cascade in COVID-19 and Long-COVID. International Journal of Sciences: Basic and Applied Research. 2026. doi:10.13140/rg.2.2.28202.48325
BibTeX
@article{Gerlach2026,
author = {Gerlach, Joachim and Baig, Abdul Mannan and Jaeger, Beate Roxane and Brogna, Carlo and König, Brigitte and McCairn, Kevin and Rixey, Charles and Mavberg, Philip and Triantos, Phillip and +, Ursula Ehrhorn and Seneff, Stephanie},
title = {Spike Protein-Mediated Compound Immunodeficiency Cascade in COVID-19 and Long-COVID},
journal = {International Journal of Sciences: Basic and Applied Research},
year = {2026},
doi = {10.13140/rg.2.2.28202.48325}
}
EUVIMED